A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
published in: Journal of Cystic Fibrosis
date of publication: 2014-01-17
main subject: phase II clinical trial, placebo, cystic fibrosis
Cites articles 32
Date
Title
Article - wd:Q36584924